DarkIris Inc (DKI) Stock Analysis
Verdict: AVOID
Relentless dilution, going-concern doubt, and an imminent 1-for-50 reverse split destroy long-term equity value despite AIGC expansion.
Investment score: 9/100
Analysis as of
Is DarkIris Inc stock worth reviewing? The TradeMates thesis
The TradeMates model classifies DarkIris as a high-risk distressed micro-cap trapped in toxic dilution and reverse-split cycles. With liquid cash under $0.25M, active going-concern warnings, and concentrated Class B control, long-term equity value faces structural downside.
7-factor investment score
- Valuation: 15/100 (weight 20%)
- Financial Health: 5/100 (weight 15%)
- Technical Momentum: 5/100 (weight 15%)
- Earnings Quality: 10/100 (weight 15%)
- Insider Sentiment: 25/100 (weight 10%)
- Analyst Consensus: 0/100 (weight 10%)
- Risk-Adjusted Return: 5/100 (weight 15%)
DarkIris Inc opportunities and risks
What speaks for DKI
- AIGC Platform Expansion
What speaks against DKI
- Toxic Warrant and Share Dilution Overhang
Peers and competitors
- 3888.HK
Frequently asked questions about DarkIris Inc (DKI)
Is DKI stock a good investment?
The TradeMates model rates DarkIris Inc as AVOID with an investment score of 9/100. The TradeMates model classifies DarkIris as a high-risk distressed micro-cap trapped in toxic dilution and reverse-split cycles. With liquid cash under $0.25M, active going-concern warnings, and concentrated Class B control, long-term equity value faces structural downside. This is algorithmic model output, not personal investment advice.
Is DKI stock a buy?
The TradeMates model verdict for DKI is AVOID with an investment score of 9/100. Treat this as a model signal to review, not a personal buy recommendation.